{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:56:21Z","timestamp":1771649781061,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10565-021-09609-w","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T13:18:35Z","timestamp":1620825515000},"page":"809-824","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["RNF144A suppresses ovarian cancer stem cell properties and tumor progression through regulation of LIN28B degradation via the ubiquitin-proteasome pathway"],"prefix":"10.1007","volume":"38","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengzhen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4810-5357","authenticated-orcid":false,"given":"Jianhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"issue":"1","key":"9609_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5115\/acb.2014.47.1.1","volume":"47","author":"S Amini","year":"2014","unstructured":"Amini S, Fathi F, Mobalegi J, Sofimajidpour H, Ghadimi T. The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines. Anat Cell Biol. 2014;47(1):1\u201311. https:\/\/doi.org\/10.5115\/acb.2014.47.1.1.","journal-title":"Anat Cell Biol"},{"issue":"1","key":"9609_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12929-018-0426-4","volume":"25","author":"AZ Ayob","year":"2018","unstructured":"Ayob AZ, Ramasamy TS. Cancer stem cells as key drivers of tumour progression. J Biomed Sci. 2018;25(1):20. https:\/\/doi.org\/10.1186\/s12929-018-0426-4.","journal-title":"J Biomed Sci"},{"key":"9609_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fgene.2017.00031","volume":"8","author":"J Balzeau","year":"2017","unstructured":"Balzeau J, Menezes MR, Cao S, Hagan JP. The LIN28\/let-7 pathway in cancer. Front Genet. 2017;8:31. https:\/\/doi.org\/10.3389\/fgene.2017.00031.","journal-title":"Front Genet"},{"issue":"11","key":"9609_CR4","first-page":"937","volume":"93","author":"CA Doubeni","year":"2016","unstructured":"Doubeni CA, Doubeni AR, Myers AE. Diagnosis and management of ovarian cancer. Am Fam Physician. 2016;93(11):937\u201344.","journal-title":"Am Fam Physician"},{"issue":"2","key":"9609_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017135","volume":"6","author":"KS Ghanta","year":"2011","unstructured":"Ghanta KS, Li DQ, Eswaran J, Kumar R. Gene profiling of MTA1 identifies novel gene targets and functions. PLoS One. 2011;6(2):e17135. https:\/\/doi.org\/10.1371\/journal.pone.0017135.","journal-title":"PLoS One"},{"issue":"3","key":"9609_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.bbadis.2018.12.006","volume":"1865","author":"S Haq","year":"2019","unstructured":"Haq S, Das S, Kim DH, Chandrasekaran AP, Hong SH, Kim KS, et al. The stability and oncogenic function of LIN28A are regulated by USP28. Biochim Biophys Acta Mol basis Dis. 2019;1865(3):599\u2013610. https:\/\/doi.org\/10.1016\/j.bbadis.2018.12.006.","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"26","key":"9609_CR7","doi-asserted-by":"publisher","first-page":"E2646","DOI":"10.1073\/pnas.1323107111","volume":"111","author":"SR Ho","year":"2014","unstructured":"Ho SR, Mahanic CS, Lee YJ, Lin WC. RNF144A, an E3 ubiquitin ligase for DNA-PKcs, promotes apoptosis during DNA damage. Proc Natl Acad Sci U S A. 2014;111(26):E2646\u201355. https:\/\/doi.org\/10.1073\/pnas.1323107111.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"9609_CR8","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","volume":"139","author":"D Iliopoulos","year":"2009","unstructured":"Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell. 2009;139(4):693\u2013706. https:\/\/doi.org\/10.1016\/j.cell.2009.10.014.","journal-title":"Cell."},{"issue":"11","key":"9609_CR9","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1038\/nm.4415","volume":"23","author":"X Jin","year":"2017","unstructured":"Jin X, Kim LJY, Wu Q, Wallace LC, Prager BC, Sanvoranart T, et al. Targeting glioma stem cells through combined BMI1 and EZH2 inhibition. Nat Med. 2017;23(11):1352\u201361. https:\/\/doi.org\/10.1038\/nm.4415.","journal-title":"Nat Med"},{"issue":"7","key":"9609_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4252\/wjsc.v11.i7.383","volume":"11","author":"N Kenda Suster","year":"2019","unstructured":"Kenda Suster N, Virant-Klun I. Presence and role of stem cells in ovarian cancer. World Journal of Stem Cells. 2019;11(7):383\u201397. https:\/\/doi.org\/10.4252\/wjsc.v11.i7.383.","journal-title":"World Journal of Stem Cells"},{"issue":"1","key":"9609_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/mol.114.091595","volume":"86","author":"A Khan","year":"2014","unstructured":"Khan A, Li D, Ibrahim S, Smyth E, Woulfe DS. The physical association of the P2Y12 receptor with PAR4 regulates arrestin-mediated Akt activation. Mol Pharmacol. 2014;86(1):1\u201311. https:\/\/doi.org\/10.1124\/mol.114.091595.","journal-title":"Mol Pharmacol"},{"key":"9609_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41698-018-0063-0","volume":"2","author":"S Kim","year":"2018","unstructured":"Kim S, Han Y, Kim SI, Kim HS, Kim SJ, Song YS. Tumor evolution and chemoresistance in ovarian cancer. NPJ precision oncology. 2018;2:20. https:\/\/doi.org\/10.1038\/s41698-018-0063-0.","journal-title":"NPJ precision oncology"},{"issue":"12","key":"9609_CR13","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1158\/0008-5472.can-10-4637","volume":"71","author":"CE King","year":"2011","unstructured":"King CE, Cuatrecasas M, Castells A, Sepulveda AR, Lee JS, Rustgi AK. LIN28B promotes colon cancer progression and metastasis. Cancer Res. 2011;71(12):4260\u20138. https:\/\/doi.org\/10.1158\/0008-5472.can-10-4637.","journal-title":"Cancer Res"},{"issue":"8","key":"9609_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012445","volume":"5","author":"D Kong","year":"2010","unstructured":"Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, et al. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One. 2010;5(8):e12445. https:\/\/doi.org\/10.1371\/journal.pone.0012445.","journal-title":"PLoS One"},{"key":"9609_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1479-5876-7-25","volume":"7","author":"CL Koo","year":"2009","unstructured":"Koo CL, Kok LF, Lee MY, Wu TS, Cheng YW, Hsu JD, et al. Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study. J Transl Med. 2009;7:25. https:\/\/doi.org\/10.1186\/1479-5876-7-25.","journal-title":"J Transl Med"},{"issue":"3","key":"9609_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","volume":"14","author":"A Kreso","year":"2014","unstructured":"Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell. 2014;14(3):275\u201391. https:\/\/doi.org\/10.1016\/j.stem.2014.02.006.","journal-title":"Cell Stem Cell"},{"issue":"10177","key":"9609_CR17","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/s0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet (London, England). 2019;393(10177):1240\u201353. https:\/\/doi.org\/10.1016\/s0140-6736(18)32552-2.","journal-title":"Lancet (London, England)"},{"key":"9609_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41392-018-0026-5","volume":"3","author":"X Lin","year":"2018","unstructured":"Lin X, Shen J, Dan P, He X, Xu C, Chen X, et al. RNA-binding protein LIN28B inhibits apoptosis through regulation of the AKT2\/FOXO3A\/BIM axis in ovarian cancer cells. Signal Transduct Target Ther. 2018;3:23. https:\/\/doi.org\/10.1038\/s41392-018-0026-5.","journal-title":"Signal Transduct Target Ther"},{"key":"9609_CR19","unstructured":"National Research Council Committee for the Update of the Guide for the C, Use of Laboratory A. The National Academies Collection: Reports funded by National Institutes of Health. In: th, editor. Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academies Press (US) National Academy of Sciences; 2011."},{"key":"9609_CR20","doi-asserted-by":"publisher","first-page":"5416923","DOI":"10.1155\/2018\/5416923","volume":"2018","author":"LTH Phi","year":"2018","unstructured":"Phi LTH, Sari IN, Yang YG, Lee SH, Jun N, Kim KS, et al. Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment. Stem Cells Int. 2018;2018:5416923\u201316. https:\/\/doi.org\/10.1155\/2018\/5416923.","journal-title":"Stem Cells Int"},{"issue":"1","key":"9609_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","volume":"14","author":"BM Reid","year":"2017","unstructured":"Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14(1):9\u201332. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2016.0084.","journal-title":"Cancer Biol Med"},{"key":"9609_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jsbmb.2015.03.010","volume":"150","author":"X Ren","year":"2015","unstructured":"Ren X, Wu X, Hillier SG, Fegan KS, Critchley HO, Mason JI, et al. Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy. J Steroid Biochem Mol Biol. 2015;150:54\u201363. https:\/\/doi.org\/10.1016\/j.jsbmb.2015.03.010.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"9609_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ygyno.2018.05.006","volume":"150","author":"I Ruscito","year":"2018","unstructured":"Ruscito I, Darb-Esfahani S, Kulbe H, Bellati F, Zizzari IG, Rahimi Koshkaki H, et al. The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: a meta-analysis. Gynecol Oncol. 2018;150(1):151\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2018.05.006.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9609_CR24","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1038\/s41598-020-59116-x","volume":"10","author":"S Samanta","year":"2020","unstructured":"Samanta S, Tamura S, Dubeau L, Mhawech-Fauceglia P, Miyagi Y, Kato H, et al. Clinicopathological significance of endoplasmic reticulum stress proteins in ovarian carcinoma. Sci Rep. 2020;10(1):2160. https:\/\/doi.org\/10.1038\/s41598-020-59116-x.","journal-title":"Sci Rep"},{"issue":"6","key":"9609_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/1758834014544891","volume":"6","author":"S Sato","year":"2014","unstructured":"Sato S, Itamochi H. Neoadjuvant chemotherapy in advanced ovarian cancer: latest results and place in therapy. Ther Adv Med Oncol. 2014;6(6):293\u2013304. https:\/\/doi.org\/10.1177\/1758834014544891.","journal-title":"Ther Adv Med Oncol"},{"issue":"5","key":"9609_CR26","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1158\/1078-0432.ccr-07-1543","volume":"14","author":"RR Seethala","year":"2008","unstructured":"Seethala RR, Gooding WE, Handler PN, Collins B, Zhang Q, Siegfried JM, Grandis JR. Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes. Clin Cancer Res. 2008;14(5):1303\u20139. https:\/\/doi.org\/10.1158\/1078-0432.ccr-07-1543.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"9609_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.stem.2013.03.005","volume":"12","author":"N Shyh-Chang","year":"2013","unstructured":"Shyh-Chang N, Daley GQ. Lin28: primal regulator of growth and metabolism in stem cells. Cell Stem Cell. 2013;12(4):395\u2013406. https:\/\/doi.org\/10.1016\/j.stem.2013.03.005.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"9609_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5\u201329. https:\/\/doi.org\/10.3322\/caac.21254.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"9609_CR29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1042\/bj20140006","volume":"458","author":"DE Spratt","year":"2014","unstructured":"Spratt DE, Walden H, Shaw GS. RBR E3 ubiquitin ligases: new structures, new insights, new questions. Biochem J. 2014;458(3):421\u201337. https:\/\/doi.org\/10.1042\/bj20140006.","journal-title":"Biochem J"},{"issue":"4","key":"9609_CR30","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.cell.2010.02.007","volume":"140","author":"SR Viswanathan","year":"2010","unstructured":"Viswanathan SR, Daley GQ. Lin28: a microRNA regulator with a macro role. Cell. 2010;140(4):445\u20139. https:\/\/doi.org\/10.1016\/j.cell.2010.02.007.","journal-title":"Cell."},{"key":"9609_CR31","doi-asserted-by":"publisher","unstructured":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama. 2013;310(20):2191\u20134. https:\/\/doi.org\/10.1001\/jama.2013.281053.\u00a0PMID: 24141714.","DOI":"10.1001\/jama.2013.281053"},{"issue":"1","key":"9609_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.canlet.2015.08.018","volume":"369","author":"X Xu","year":"2015","unstructured":"Xu X, Chai S, Wang P, Zhang C, Yang Y, Yang Y, et al. Aldehyde dehydrogenases and cancer stem cells. Cancer Lett. 2015;369(1):50\u20137. https:\/\/doi.org\/10.1016\/j.canlet.2015.08.018.","journal-title":"Cancer Lett"},{"issue":"6","key":"9609_CR33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/14737159.2017.1326820","volume":"17","author":"WL Yang","year":"2017","unstructured":"Yang WL, Lu Z, Bast RC Jr. The role of biomarkers in the management of epithelial ovarian cancer. Expert Rev Mol Diagn. 2017;17(6):577\u201391. https:\/\/doi.org\/10.1080\/14737159.2017.1326820.","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"9609_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020;5(1):8. https:\/\/doi.org\/10.1038\/s41392-020-0110-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"9609_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41467-018-08127-4","volume":"10","author":"AV Yermalovich","year":"2019","unstructured":"Yermalovich AV, Osborne JK, Sousa P, Han A, Kinney MA, Chen MJ, et al. Lin28 and let-7 regulate the timing of cessation of murine nephrogenesis. Nat Commun. 2019;10(1):168. https:\/\/doi.org\/10.1038\/s41467-018-08127-4.","journal-title":"Nat Commun"},{"issue":"1-2","key":"9609_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cell.2011.11.050","volume":"148","author":"WC Zhang","year":"2012","unstructured":"Zhang WC, Shyh-Chang N, Yang H, Rai A, Umashankar S, Ma S, et al. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell. 2012;148(1-2):259\u201372. https:\/\/doi.org\/10.1016\/j.cell.2011.11.050.","journal-title":"Cell."},{"issue":"1","key":"9609_CR37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.stem.2016.05.009","volume":"19","author":"J Zhang","year":"2016","unstructured":"Zhang J, Ratanasirintrawoot S, Chandrasekaran S, Wu Z, Ficarro SB, Yu C, et al. LIN28 regulates stem cell metabolism and conversion to primed pluripotency. Cell Stem Cell. 2016;19(1):66\u201380. https:\/\/doi.org\/10.1016\/j.stem.2016.05.009.","journal-title":"Cell Stem Cell"},{"issue":"55","key":"9609_CR38","doi-asserted-by":"publisher","first-page":"94505","DOI":"10.18632\/oncotarget.21784","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Liao XH, Xie HY, Shao ZM, Li DQ. RBR-type E3 ubiquitin ligase RNF144A targets PARP1 for ubiquitin-dependent degradation and regulates PARP inhibitor sensitivity in breast cancer cells. Oncotarget. 2017;8(55):94505\u201318. https:\/\/doi.org\/10.18632\/oncotarget.21784.","journal-title":"Oncotarget."},{"issue":"4","key":"9609_CR39","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/cam4.1324","volume":"7","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Yang YL, Zhang FL, Liao XH, Shao ZM, Li DQ. Epigenetic silencing of RNF144A expression in breast cancer cells through promoter hypermethylation and MBD4. Cancer medicine. 2018;7(4):1317\u201325. https:\/\/doi.org\/10.1002\/cam4.1324.","journal-title":"Cancer medicine"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-021-09609-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-021-09609-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-021-09609-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T07:09:45Z","timestamp":1664521785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-021-09609-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["9609"],"URL":"https:\/\/doi.org\/10.1007\/s10565-021-09609-w","relation":{},"ISSN":["0742-2091","1573-6822"],"issn-type":[{"value":"0742-2091","type":"print"},{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,11]]},"assertion":[{"value":"7 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the standards upheld by the Ethics Committee of The Yancheng Clinical College of Xuzhou Medical University, The First People\u2019s Hospital of Yancheng. All animal experiments were approved by the Ethics Committee of The Yancheng Clinical College of Xuzhou Medical University, The First People\u2019s Hospital of Yancheng.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from a legally authorized representative(s) for anonymized patient information to be published in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}